Evidence map›Paper›PMID 40080201›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025

Patient-reported outcomes in head and neck cancer: a cross-sectional analysis of quality of life domains across early and advanced UICC stages.

Moritz Allner, Atina Rak, Matthias Balk, Robin Rupp, Omar Almajali, Henriette Tamse, Juliane Gschossmann, Matti Sievert, Sarina Müller, Michael Koch and 5 more

Abstract read
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Responsiveness and clinical utility of patient-reported outcome instruments in head and neck cancer: a systematic review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Moritz AllnerDepartment of Otorhinolaryngology, Friedrich-Alexander-Universität (FAU), Head & Neck Surgery, Comprehensive Cancer Center Erlangen-EMN, Erlangen-Nuremberg, Germany. moritz.allner@uk-erlangen.de.
Atina RakDepartment of Otorhinolaryngology, Friedrich-Alexander-Universität (FAU), Head & Neck Surgery, Comprehensive Cancer Center Erlangen-EMN, Erlangen-Nuremberg, Germany.
Matthias BalkDepartment of Otorhinolaryngology, Friedrich-Alexander-Universität (FAU), Head & Neck Surgery, Comprehensive Cancer Center Erlangen-EMN, Erlangen-Nuremberg, Germany.
Robin RuppDepartment of Otorhinolaryngology, Friedrich-Alexander-Universität (FAU), Head & Neck Surgery, Comprehensive Cancer Center Erlangen-EMN, Erlangen-Nuremberg, Germany.
Omar AlmajaliDepartment of Otorhinolaryngology, Friedrich-Alexander-Universität (FAU), Head & Neck Surgery, Comprehensive Cancer Center Erlangen-EMN, Erlangen-Nuremberg, Germany.
Henriette TamseDepartment of Otorhinolaryngology, Friedrich-Alexander-Universität (FAU), Head & Neck Surgery, Comprehensive Cancer Center Erlangen-EMN, Erlangen-Nuremberg, Germany.
Juliane GschossmannDepartment of Otorhinolaryngology, Friedrich-Alexander-Universität (FAU), Head & Neck Surgery, Comprehensive Cancer Center Erlangen-EMN, Erlangen-Nuremberg, Germany.
Matti SievertDepartment of Otorhinolaryngology, Friedrich-Alexander-Universität (FAU), Head & Neck Surgery, Comprehensive Cancer Center Erlangen-EMN, Erlangen-Nuremberg, Germany.
Sarina MüllerDepartment of Otorhinolaryngology, Friedrich-Alexander-Universität (FAU), Head & Neck Surgery, Comprehensive Cancer Center Erlangen-EMN, Erlangen-Nuremberg, Germany.
Michael KochDepartment of Otorhinolaryngology, Friedrich-Alexander-Universität (FAU), Head & Neck Surgery, Comprehensive Cancer Center Erlangen-EMN, Erlangen-Nuremberg, Germany.
Heinrich IroDepartment of Otorhinolaryngology, Friedrich-Alexander-Universität (FAU), Head & Neck Surgery, Comprehensive Cancer Center Erlangen-EMN, Erlangen-Nuremberg, Germany.
Magdalena GostianDepartment of Anesthesiology and Intensive Care Medicine, Malteser Waldkrankenhaus St. Marien, Erlangen, Germany.
Markus HechtDepartment of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Homburg/Saar, Germany.
Elisabeth WimmerDepartment of Otorhinolaryngology, Merciful Brothers Hospital St. Elisabeth, Head & Neck Surgery, 94315, Straubing, Germany.
Antoniu-Oreste GostianDepartment of Otorhinolaryngology, Merciful Brothers Hospital St. Elisabeth, Head & Neck Surgery, 94315, Straubing, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHead and neck cancer (HNC) patients experience a variety of post-treatment symptoms that affect their quality of life (QoL). This study aims to assess the most prevalent symptoms and their relationship to cancer stage (UICC I-IV) while identifying areas for targeted intervention.

methodsA cross-sectional study was conducted involving 340 HNC patients at the University Hospital Erlangen from January to December 2019. QoL and its domains were assessed using the German version of the University of Washington Quality of Life Questionnaire Version 4 (UW-QoL v.4), with comparisons made between early-stage (UICC I & II, n = 180) and advanced-stage (UICC III & IV, n = 160) patients. Statistical analysis examined differences in QoL and its individual domains.

resultsAdvanced-stage patients reported significantly greater impairments in several QoL domains, including swallowing (p = 0.003, η

conclusionAdvanced-stage HNC patients experience a significantly higher burden of physical symptoms, particularly issues with swallowing, saliva, and taste, necessitating early and targeted interventions. Psychological issues are also prevalent and should be addressed in both early- and advanced-stage patients. Despite non-significant differences in some symptoms, their clinical relevance may still be important, particularly in individual cases. Comprehensive care, including physical and emotional support, is essential to improving long-term QoL for HNC patients. Further research should focus on longitudinal assessments and clinically meaningful thresholds for symptom management.

Indexed as

Head and Neck NeoplasmsPatient Reported Outcome MeasuresQuality of LifeAdultAgedAged, 80 and overCross-Sectional StudiesFemaleHumansMaleMiddle AgedNeoplasm StagingSurveys and QuestionnairesAdvanced-stage cancerCancerDisease stageEarly-stage cancerFollow-upHead and neck cancerIndividualized carePatient-reported outcomePhysical symptomsPsychological symptomsQuality of lifeSurvivorship

Identifiers

PMID40080201
PMCPMC11906576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.